TY - JOUR
T1 - Riboflavin-responsive lipid-storage myopathy in elderly patients
AU - Sadeh, Menachem
AU - Dory, Amir
AU - Lev, Dorit
AU - Yosovich, Keren
AU - Dabby, Ron
N1 - Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2024/1/15
Y1 - 2024/1/15
N2 - There are scarce reports of riboflavin-responsive lipid storage myopathy in elderly patients with onset in their sixties. We describe three elderly patients with riboflavin-responsive lipid-storage myopathy. All three patients (aged 67–71 years on first examination) had subacute onset of neck extensors and proximal limb weakness progressing to inability to rise from a sitting position or to walk. Muscle biopsies showed vacuoles with lipid content, mainly in type 1 fibers. Genetic analysis failed to identify any pathogenic variant in one patient, identified a heterozygous variant of uncertain significance c.812 A > G; p.Tyr271Cys in the ETFDH gene in the second patient, and revealed a heterozygote likely pathogenic variant c.1286-2 A > C in the ETFDH gene predicted to cause abnormal splicing in the third patient. All patients responded to treatment with riboflavin and carnitine, and regained normal strength. This report emphasizes the importance of muscle biopsy in revealing treatable lipid storage myopathy in elderly patients with progressive myopathy of unidentifiable cause.
AB - There are scarce reports of riboflavin-responsive lipid storage myopathy in elderly patients with onset in their sixties. We describe three elderly patients with riboflavin-responsive lipid-storage myopathy. All three patients (aged 67–71 years on first examination) had subacute onset of neck extensors and proximal limb weakness progressing to inability to rise from a sitting position or to walk. Muscle biopsies showed vacuoles with lipid content, mainly in type 1 fibers. Genetic analysis failed to identify any pathogenic variant in one patient, identified a heterozygous variant of uncertain significance c.812 A > G; p.Tyr271Cys in the ETFDH gene in the second patient, and revealed a heterozygote likely pathogenic variant c.1286-2 A > C in the ETFDH gene predicted to cause abnormal splicing in the third patient. All patients responded to treatment with riboflavin and carnitine, and regained normal strength. This report emphasizes the importance of muscle biopsy in revealing treatable lipid storage myopathy in elderly patients with progressive myopathy of unidentifiable cause.
KW - Carnitine
KW - ETFDH
KW - Genetic analysis
KW - Lipid storage myopathy
KW - Riboflavin
UR - http://www.scopus.com/inward/record.url?scp=85178157783&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2023.122808
DO - 10.1016/j.jns.2023.122808
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38043332
AN - SCOPUS:85178157783
SN - 0022-510X
VL - 456
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 122808
ER -